Intravascular Ultrasound Market
Report ID: SQMIG35A3895
Report ID: SQMIG35A3895
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3895 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
116
|Figures:
72
Global Intravascular Ultrasound Market size was valued at USD 1.08 Billion in 2024 and is poised to grow from USD 1.17 Billion in 2025 to USD 2.15 Billion by 2033, growing at a CAGR of 7.93% during the forecast period (2026-2033).
Intravascular ultrasound (IVUS) is an intravascular imaging technique employed during catheter-based cardiac and peripheral interventions to provide cross-sectional vessel images and accurate lumen measurements, and its primary driver is the clinical imperative for procedural precision because optimized stent sizing and lesion assessment reduce restenosis, minimize complications, and improve long-term outcomes. Over the last twenty years the market matured from limited research applications to routine cath-lab use as probe miniaturization, higher-resolution imaging, and integration with navigation systems lowered clinical barriers; for example, phased-array catheters and co-registration with angiography have enabled complex PCI and peripheral interventions to be planned and executed confidently.
Regulatory endorsements and reimbursement expansion have acted as pivotal catalysts because when payers recognize IVUS-guided procedures as cost-effective the adoption by hospitals increases, triggering demand for compatible consoles and disposable catheters and enabling manufacturers to scale production and invest in R&D. Consequently, lowered unit costs and enhanced device availability create opportunities in emerging markets where rising cardiovascular disease burdens and expanding cath-lab infrastructure permit real-world deployment such as IVUS-guided complex PCI in tertiary centers and peripheral limb salvage programs that reduce repeat interventions, while cloud-based analytics and AI-driven image interpretation promise workflow efficiency that reinforce clinician uptake and boost margins.
How is AI enhancing diagnostic precision in the intravascular ultrasound market?
AI is improving diagnostic precision in intravascular ultrasound by enhancing image clarity, automating tissue segmentation and highlighting plaque characteristics. These capabilities allow more consistent identification of vulnerable lesions and clearer guidance for stent sizing and placement. Systems that fuse IVUS with angiography and physiologic data provide context during procedures and reduce operator variability. Deep learning models support pullback interpretation, feature detection and co registration, which makes reports more reproducible and speeds clinical decision making. Together these advances push the market toward integrated imaging platforms and clinician decision support tools that prioritize accuracy and workflow efficiency.
Philips in March 2026, launched IntraSight Plus to unite intravascular ultrasound physiology and AI driven co registration for real time procedural guidance. This development supports market growth by making advanced imaging easier to use in busy cath labs and by speeding interpretation and treatment confirmation, which boosts clinician confidence and device adoption.
Market snapshot - (2026-2033)
Global Market Size
USD 1.08 Billion
Largest Segment
IVUS Catheters
Fastest Growth
IVUS Catheters
Growth Rate
7.93% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global intravascular ultrasound market is segmented by product type, technology, application, end-user and region. Based on product type, the market is segmented into IVUS Consoles and IVUS Catheters. Based on technology, the market is segmented into Solid-State IVUS and Rotational IVUS. Based on application, the market is segmented into Coronary Artery Disease, Peripheral Arterial Disease, Structural Heart Disease and Others. Based on end-user, the market is segmented into Hospitals, Cardiac Catheterization Labs and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
IVUS catheters segment dominates with large global intravascular ultrasound market share because catheters are the direct clinical interface that deliver intraluminal visualization during interventions, enabling accurate lesion assessment, stent sizing, and real time guidance. Their continuous design improvements, disposable formats, and clinician familiarity drive routine use in interventional workflows, fostering procurement preference and steady consumable revenue, which sustains vendor investment and entrenches catheters as the primary revenue and utility driver in the market.
As per global intravascular ultrasound market outlook, IVUS Consoles are emerging as the fastest growing area because advances in processing, image reconstruction, and software analytics enable real time guidance and workflow efficiency. Enhanced connectivity with cardiac procedure systems and modular upgrade paths increase procurement appeal, creating recurring service models and expanding adoption across procedural settings, thereby unlocking new commercial opportunities beyond consumables.
As per global intravascular ultrasound market forecast, solid state IVUS segment dominates because solid state transducer arrays provide stable, high fidelity imaging with reduced mechanical complexity, meeting clinician demand for consistent intravascular visualization. The technology’s reliability, easier integration with digital processing platforms, and suitability for miniaturized catheter designs drive broad acceptance in diagnostic and interventional workflows, encouraging vendors to align product roadmaps and clinical protocols around detailed plaque characterization and guided therapy planning.
However, rotational IVUS is emerging as the fastest growing area because improvements in catheter mechanics and cost effective designs enhance rotational imaging for select lesion morphologies. Expansion into peripheral and hybrid applications and recent regulatory approvals widen clinical use, prompting vendors to focus on product updates and clinician training that unlock new growth opportunities.
To get detailed segments analysis, Request a Free Sample Report
As per global intravascular ultrasound market regional outlook North America dominance drives from a convergence of advanced clinical infrastructure, concentrated innovation, and a well established ecosystem for medical technology adoption. Academic medical centers and specialized cardiovascular clinics drive clinical validation and refinement of intravascular imaging techniques, while a dense network of device manufacturers and research partnerships accelerates product development. Reimbursement frameworks and professional guidelines in the region tend to support use of adjunctive imaging during complex interventions, encouraging physician uptake. Strong capital markets and experienced regulatory pathways facilitate commercialization of new platforms, and focused clinician training and continuing education ensure a skilled user base. Collectively these factors create an environment where new intravascular ultrasound innovations are rapidly introduced, validated, and integrated into routine interventional practice.
As per global intravascular ultrasound market regional forecast, United States is characterized by early clinical adoption, extensive device manufacturer presence, and robust clinical research activity. Leading academic centers and high volume catheterization laboratories function as hubs for real world evaluation and technique refinement, supporting widespread procedural use. Reimbursement clarity and specialized training programs contribute to consistent clinician engagement, while partnerships between industry and healthcare institutions promote continuous technology iteration and commercialization.
Canada is shaped by a centralized healthcare delivery model and a focus on evidence based adoption of imaging technologies. Major tertiary cardiac centers and provincial referral networks drive concentrated use and training, while health technology assessment processes influence diffusion into broader practice. Collaboration between clinical leaders and industry, along with emphasis on cost effective care pathways, supports targeted implementation in high acuity settings.
Rapid expansion in Europe is being driven by a blend of clinical guideline evolution, concentrated centers of excellence, and increased collaboration among stakeholders across national health systems. There is growing clinician preference for precision imaging to optimize interventional outcomes, which is supported by targeted investments in catheterization laboratory modernization and professional training. European device manufacturers and multidisciplinary consortia contribute to localized innovation and adaptation of systems to regional practice patterns. Cross border research collaborations and shared registries enhance evidence generation, while evolving reimbursement and health technology assessment frameworks are increasingly recognizing the clinical value of intravascular imaging. These dynamics combine to promote accelerated diffusion across key markets and to stimulate competitive offerings tailored to diverse payer environments.
Germany benefits from a dense network of specialized cardiac centers and strong engagement between clinicians and local device developers. High procedural volumes at tertiary hospitals and active clinical research communities foster rigorous evaluation and routine integration of intravascular imaging. Reimbursement mechanisms and hospital investment priorities support modernization of interventional suites, enabling focused adoption across major metropolitan regions.
United Kingdom is experiencing rapid uptake driven by national guideline influence, structured training pathways, and investments in interventional cardiology services. NHS centers of excellence and leading teaching hospitals function as innovation adopters, supporting dissemination through clinical networks. Collaboration between clinicians, commissioning bodies, and industry facilitates evidence based implementation and broader access across regional cardiac services.
France is emerging through concentrated adoption in university hospitals and research institutes that emphasize imaging guided interventions. National professional societies and collaborative research initiatives contribute to clinical validation, while health system procurement processes and regional hospital priorities shape gradual diffusion into community cardiac centers. Local innovation and clinician engagement support steady market development.
Asia Pacific is strengthening its position through strategic investments in interventional infrastructure, expanding clinical expertise, and growing collaboration between multinational manufacturers and regional partners. Regional healthcare systems are upgrading catheterization laboratories and prioritizing training programs to build procedural competence in advanced imaging modalities. Local device development and manufacturing capabilities are improving, supported by targeted regulatory modernization that facilitates clinical evaluation and market entry. Cross border clinical partnerships and tailored product offerings address specific anatomical and procedural needs common in the region, while burgeoning centers of excellence in metropolitan areas provide important demonstration sites. These combined efforts are driving a deeper regional footprint for intravascular ultrasound and fostering a competitive landscape for innovation and adoption.
Japan is anchored by a culture of medical device innovation and a mature clinical community focused on precision imaging. High standards of clinical evaluation and strong relationships between industry and leading cardiology centers encourage adoption of advanced intravascular techniques. Local manufacturers and multinational firms collaborate to adapt technologies to practice needs, supporting sustained integration within tertiary hospitals.
South Korea is advancing through rapid modernization of interventional cardiology services and proactive industry support for clinical training. Tertiary hospitals and specialized cardiac centers drive early adoption, while government initiatives and export oriented device development foster a competitive domestic ecosystem. Partnerships between clinicians and manufacturers enable practical adaptation and wider dissemination across urban healthcare institutions.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Cardiovascular Disease Burden
Technological Advancements In IVUS Systems
High Procedure And Device Costs
Limited Reimbursement In Some Regions
Request Free Customization of this report to help us to meet your business objectives.
Competitive dynamics in the global intravascular ultrasound industry are shaped by targeted product launches, regulatory clearances and strategic financing, which push rivals toward mergers and acquisitions, clinical partnerships and rapid technology differentiation. Recent real examples include major vendors introducing new coronary imaging catheters, FDA clearing novel IVUS systems, and venture-backed startups exiting stealth with Series A financing to commercialize AI enabled IVUS platforms.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global intravascular ultrasound market growth is positioned for steady growth, a key driver is the rising cardiovascular disease burden and a second driver is AI-enhanced image interpretation that improves procedural precision. Adoption is concentrated in North America, which is the dominating region due to advanced clinical infrastructure and favorable reimbursement. IVUS catheters are the dominating segment because they serve as the direct clinical interface and generate recurring consumable revenue. A significant restraint is high procedure and device costs that limit adoption in budget-constrained hospitals and emerging markets. Despite this, ongoing console improvements, hybrid imaging workflows and regulatory support are expected to broaden clinical use and vendor investment.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 1.08 Billion |
| Market size value in 2033 | USD 2.15 Billion |
| Growth Rate | 7.93% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Intravascular Ultrasound Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Intravascular Ultrasound Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Intravascular Ultrasound Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Intravascular Ultrasound Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Intravascular Ultrasound Market size was valued at USD 1.08 Billion in 2024 and is poised to grow from USD 1.17 Billion in 2025 to USD 2.15 Billion by 2033, growing at a CAGR of 7.93% during the forecast period (2026-2033).
Competitive dynamics in the global intravascular ultrasound market are shaped by targeted product launches, regulatory clearances and strategic financing, which push rivals toward mergers and acquisitions, clinical partnerships and rapid technology differentiation. Recent real examples include major vendors introducing new coronary imaging catheters, FDA clearing novel IVUS systems, and venture-backed startups exiting stealth with Series A financing to commercialize AI enabled IVUS platforms. 'Philips (Volcano)', 'Boston Scientific', 'Terumo Corporation', 'InfraReDx', 'Acist Medical Systems', 'Siemens Healthineers', 'GE Healthcare', 'Infraredx (Nipro)', 'Rontis Corporation', 'Hexacath', 'Conavi Medical', 'Nuvectra Corporation', 'Sound Technologies', 'SciMed Life Systems', 'OrbusNeich'
High and increasing rates of cardiovascular conditions lead clinicians to seek improved diagnostic and interventional tools, making intravascular ultrasound more integral to care pathways. IVUS offers enhanced visualization of vessel morphology and plaque characteristics, which supports precise stent sizing and deployment and reduces procedural uncertainty. As a result, hospitals and cardiology centers prioritize adoption to improve clinical decision making and procedural outcomes, driving procurement of IVUS systems and related services, expanding clinical use cases and encouraging investment in training and infrastructure to integrate the technology broadly.
Ai-Enhanced Image Interpretation: Adoption of advanced machine learning pattern recognition is accelerating clinician confidence in intravascular ultrasound interpretation, enabling clearer lesion characterization and streamlined decision making. Vendor focus on interoperable software, workflow integration, and visualization supports broader clinician uptake. Improved automated measurements and standardized reporting reduce variability and enhance collaboration across care teams, fostering proactive treatment planning and consistent follow up. This qualitative shift emphasizes diagnostic value, enhances perceived utility of IVUS, and encourages integration with broader catheterization lab workflows and training programs.
Why does North America Dominate the Global Intravascular Ultrasound Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
